Compensatory mechanisms of estrogen mediated protection from EAE in IL-10 KO mice

IL-10 KO 小鼠雌激素介导的 EAE 保护的补偿机制

基本信息

  • 批准号:
    10263144
  • 负责人:
  • 金额:
    $ 15.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-14 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Research Summary Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system that results in neurological deficits from demyelination and neuron loss from chronic neuroinflammation. MS is more prevalent in women yet improvement in clinical symptoms occurs during pregnancy followed by disease exacerbations post-partum. It is well accepted that sex hormones have immunoregulatory properties and may protect individuals with MS during pregnancy. Our previous work has shown pretreatment with low dose estrogen (17β- estradiol, E2) protects mice from developing experimental autoimmune encephalomyelitis (EAE) and promotes regulatory B cells. We have demonstrated that E2 protects mice by inducing regulatory B cells that express PD- L1 and/or IL-10. Recently we showed E2 can protect IL-10 KO mice from developing EAE (indicating that IL-10 is not required for protection) and that these mice up regulate proteins in the PD-1/PD-L1/2 pathway as well as increasing different subsets of regulatory B cells. In this proposal we thus will examine in detail these two major pathways through which E2 appears to protect IL-10 KO mice during EAE in order to address our hypothesis that IL-10 knockout mice are protected from EAE by E2 through compensatory mechanisms. Aim 1, will define the role of the PD-1/PD-L pathway in protecting IL-10 knockout mice compared to wild type mice. PD-L1, PD-L2, and PD-1 will be inhibited with neutralizing antibodies to determine the extent of compensation provided by each protein in E2 pretreated IL-10 KO mice with EAE; Aim 2, will determine which subsets of regulatory B cells are compensating for the loss of IL-10 secreting regulatory B cells in E2 mediated protection of IL-10 knockout mice. Regulatory B cells from the spleen and lymph nodes will be examined in E2 pretreated wild type and IL-10 KO EAE mice to determine which regulatory B cells are produced in each strain of mouse; Aim 3, will identify which cytokine and chemokine pathways are up/down-regulated in E2 pretreated mice lacking IL-10 compared to wild type mice. Spinal cords will be evaluated using a cytokine array and RT-PCR analysis at 21 days post immunization in four groups of mice: wild type + E2, wild type + sham, IL-10 KO + E2, and IL-10 + sham. Overall this proposal will provide a more comprehensive understanding of the immunoregulatory properties of E2 and could lead to the identification of dominant pathways that could be activated or expanded for the treatment of MS.
研究总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Halina Offner其他文献

Halina Offner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Halina Offner', 18)}}的其他基金

Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    8660356
  • 财政年份:
    2013
  • 资助金额:
    $ 15.75万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    8558759
  • 财政年份:
    2013
  • 资助金额:
    $ 15.75万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    8851694
  • 财政年份:
    2013
  • 资助金额:
    $ 15.75万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    9293408
  • 财政年份:
    2013
  • 资助金额:
    $ 15.75万
  • 项目类别:
Estrogen-Induced Regulatory B Cells Protect Against EAE & Limit CNS Inflammation
雌激素诱导的调节性 B 细胞可预防 EAE
  • 批准号:
    9068255
  • 财政年份:
    2013
  • 资助金额:
    $ 15.75万
  • 项目类别:
Sex differences in brain inflammation in experimental stroke
实验性脑卒中脑部炎症的性别差异
  • 批准号:
    8629805
  • 财政年份:
    2012
  • 资助金额:
    $ 15.75万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗死
  • 批准号:
    8186316
  • 财政年份:
    2011
  • 资助金额:
    $ 15.75万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗塞
  • 批准号:
    8690181
  • 财政年份:
    2011
  • 资助金额:
    $ 15.75万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗死
  • 批准号:
    8320086
  • 财政年份:
    2011
  • 资助金额:
    $ 15.75万
  • 项目类别:
Regulatory B-cells Limit CNS Inflammation and Infarct in Experimental Stroke
调节性 B 细胞限制实验性中风中的中枢神经系统炎症和梗塞
  • 批准号:
    8509042
  • 财政年份:
    2011
  • 资助金额:
    $ 15.75万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
    Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 15.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了